Home > News Center > Jordan Medical Device Registration: 20 JFDA FAQs on Classification, Testing and Post-Market Duties (2026)

Jordan Medical Device Registration: 20 JFDA FAQs on Classification, Testing and Post-Market Duties (2026)

Nov 13, 2026 Registration Insights 0 views

Market access for medical devices in Jordan cannot be simplified to “submit the dossier, obtain the registration certificate, and start importing”. The current framework has to be assessed together with the 2019 Guidelines on the Circulation of Medical Devices, Sterilisers and Disinfectants, Testing Regulation No. 41 of 2024 and the 2025 Testing Instructions.

In particular, note that not all medical devices follow the same registration pathway, and not all products go through the same laboratory testing procedures.

This article answers 20 common questions covering the regulator, legal basis, product classification, applicants, testing procedures, post-market obligations and practical risks.

1. Regulatory Framework and Applicants

Q1 Which authority regulates medical devices in Jordan?

Answer: Medical devices in Jordan are regulated primarily by the Jordan Food and Drug Administration (JFDA).

The JFDA was established by Interim Law No. 31 of 2003 and confirmed by Law No. 41 of 2008 as a public institution with independent legal personality and financial and administrative independence.

Specific medical device matters are handled by the JFDA Directorate of Medical Devices and Supplies, mainly covering registration of imported and locally manufactured devices, circulation licensing, testing coordination and post-market surveillance.

Q2 Which regulations govern Jordanian medical device registration?

Answer: The main legal basis can be organised into the following levels:

Regulation or documentMain role
JFDA Law No. 41 of 2008Establishes the legal status and duties of the JFDA
Drug and Pharmacy Law No. 12 of 2013 and its amendmentsBasis for medical device regulation, circulation and related authorisations
Guidelines on the Circulation of Medical Devices, Sterilisers and Disinfectants (2019)Classification, registration, import and circulation requirements for medical devices
Testing Regulation No. 41 of 2024 for Medical DevicesTesting and circulation requirements for medical devices and other products
Medical Device Testing Instructions (2025)Detail initial testing, post-market testing, sampling, re-testing and the handling of non-conforming products

Among these, the 2019 Circulation Guidelines are the key reference for determining whether a product needs registration and which access pathway applies; the 2024 Regulation and the 2025 Instructions mainly govern testing procedures.

Q3 What did Testing Regulation No. 41 of 2024 change?

Answer: The core change is an institutional separation between medical device testing and registration procedures, making testing a key step in the circulation application process.

The full name of the regulation is:

Testing Regulation No. 41 of 2024 for Medical Devices, Sterilisers, Disinfectants and Cosmetics.

The regulation was published in Jordan Official Gazette No. 5937 dated 16 July 2024, entered into force 30 days after publication, and replaced the previous testing regulation No. 89 of 2017.

Official JFDA explanations state clearly that the new regulation separates testing from registration for medical devices and other products, making testing one of the procedures for applying for circulation, while strengthening post-market sampling and testing.

Impact on manufacturers: launch plans cannot be scheduled on registration review timelines alone; manufacturers also need to assess whether the product requires initial testing, the time needed to prepare for testing, and subsequent circulation approvals.

Q4 Can foreign manufacturers apply to the JFDA directly?

Answer: In practice, applications are usually handled through local Jordanian importers and JFDA-recognised authorised persons.

Under the definitions in the 2019 Circulation Guidelines, importers include drug warehouses, institutions or companies that import medical devices, sterilisers and disinfectants into Jordan.

The regulations also set out the requirements for the Authorised Person, i.e. a person authorised by the importer and recognised by the Directorate of Medical Devices and Supplies to handle related matters, who should hold the prescribed professional qualifications.

Chinese manufacturers should therefore confirm in advance:

  • whether the Jordanian partner holds the required import and business qualifications;
  • whether a recognised authorised person has been appointed;
  • whether the manufacturer’s authorisation documents match the local applicant;
  • how registration, import, testing and post-market responsibilities are divided.

2. Product Classification and Application Process

Q5 How are medical devices classified in Jordan? Do all classes require registration?

Answer: The 2019 Circulation Guidelines adopt a classification framework based on the European medical device directives, covering Class I, Class IIa, Class IIb, Class III and active implantable devices.

Access pathways are not identical for all classes:

Product classStandard access pathway
Class IIn principle no routine registration, but import and circulation licensing requirements still apply
Class IIaIn principle no routine registration, but import and circulation licensing requirements still apply
Class IIbRegistration application submitted as required
Class IIIRegistration application submitted as required
Special products listed in Annex 7Even if they fall in another risk class, may require registration under the annex provisions

Note in particular that Class I and Class IIa do not mean full exemption from oversight. Products listed in Annex 7, products with special uses or products meeting other specific conditions should be assessed under the corresponding provisions to determine whether registration is required.

Before applying, manufacturers should first complete product classification and an annex applicability assessment, rather than determining the registration pathway by risk class alone.

Q6 Which system is used to process medical device matters in Jordan?

Answer: The JFDA operates the Cosmo e-services system:

https://application.jfda.jo/Cosmo

The system login page lists a “Cosmetics and Medical Devices/Supplies” service entry and offers new user registration.

Applicants should use the appropriate e-service entry for bookings or related submissions according to the current service type and JFDA requirements.

Q7 Once the registration certificate is obtained, can the product be imported and sold directly?

Answer: Not necessarily – registration, testing and shipment-by-shipment import approval must be distinguished.

For products requiring registration and initial testing, the typical sequence is:

Step 1: Product registration

Under the 2019 Circulation Guidelines, products meeting the registration requirements submit an application and obtain the corresponding registration approval.

Step 2: Initial testing

Under the 2025 Testing Instructions, after the registration certificate is issued, the applicant provides the certificate and technical documentation to the laboratory and completes initial testing as required by the laboratory.

Step 3: Circulation approval

Once the testing results comply, the relevant JFDA laboratory affairs department issues the circulation letter (kitab al-tadawul) as required.

Step 4: Import invoice and import approval

The importer also completes import invoice review, licensing and related formalities under the applicable procedures.

Note that:

  • not all classes require routine registration;
  • not all medical devices undergo the same laboratory testing;
  • whether testing and the specific import procedures apply should be judged by product class, testing requirements and the applicable JFDA procedures.

A registration certificate is therefore not equivalent to having completed all import and circulation formalities.

Q8 What documents are usually required for laboratory testing?

Answer: Article 4 of the 2025 Testing Instructions governs the documents for testing submissions.

For samples submitted for circulation, the main documents are:

  • Original referral form: stamped and signed, including the financial receipt;
  • Import invoice: for imported samples, an import invoice processed as required and stamped by the Directorate of Medical Devices and Supplies;
  • Batch test report (CoA): covering all batches on the invoice that require testing, with test items covering all items listed in the approved finished product specification in the technical file.

In addition, depending on the actual testing requirements, the laboratory may ask the applicant to provide:

  • reference standards and their test reports for active ingredients;
  • chromatography columns, special chemical reagents and other laboratory supplies;
  • complete technical documentation;
  • for unregistered samples and donated samples, possibly the finished product composition, specifications and analytical methods;
  • applicable pharmacopoeial documentation for pharmacopoeial products.

Practical reminder: the CoA should match the finished product specification and test items in the approved technical file. Providing only part of the test items may not satisfy the laboratory’s requirements.

3. Special Product Testing and Sampling Requirements

Q9 What special testing requirements apply to surgical sutures, medical gloves and medical gases?

Answer: Article 4 of the 2025 Testing Instructions contains specific provisions for certain products.

1. Surgical sutures

  • for registration purposes, samples are tested only once;
  • the full technical file must be provided at submission, including product composition, finished product specification, analytical methods, a stability study summary and the batch CoA;
  • after the testing results are issued, adding corresponding specifications or sizes requires a formal application, with a related letter issued by the device registration department.

2. Medical gloves

Different sampling approaches apply depending on the product type, batch and size combinations on the invoice:

ScenarioStandard testing samplingOther samples
Same product type, same batch number, different sizesOne size sampled per five sizesRemaining sizes undergo sterility testing
Same product type, different batch numbers, different sizes50% of the batches sampled, one size selected per batchRemaining sizes undergo sterility testing

Specific sample quantities should follow the sampling quantity table published by the laboratory and the related notices.

3. Medical gases

  • samples are drawn on site by JFDA sampling staff in accordance with procedures;
  • samples must comply with the applicable Jordanian standards, including requirements for colour, valves, pressure and weight;
  • samples are sent to the Royal Scientific Society (RSS) or a JFDA-recognised institution for testing;
  • before non-conforming samples are destroyed, the JFDA should be notified so that the relevant personnel can participate in the supervision as required.

Q10 How are Family series products sampled?

Answer: For registered medical devices grouped under a Family series that require testing, Article 4 of the 2025 Testing Instructions provides:

representative samples are drawn at 20% of the batch quantity corresponding to the product type with the largest number of batches on the invoice, and submitted for testing.

This means the JFDA accepts Family-series sampling arrangements in specific testing scenarios, but it should not be read as meaning that only one sample is drawn per series.

Q11 Can priority testing be requested? How long does it take?

Answer: Yes, but annual quantity limits apply.

Under Article 6 of the 2025 Testing Instructions:

  • the priority testing application is submitted to the laboratory affairs department of the Directorate of Medical Devices and Supplies;
  • the application is forwarded to the laboratory for assessment to confirm that routine work is not affected and testing conditions are available;
  • each company, agent or institution may request priority testing for no more than 3 samples per year.

The result timeframes for priority testing are as follows:

Testing typePriority testing result timeframe
Samples submitted for circulation16 working days
Initial testing samples30 working days

The above periods are counted from the date the samples are delivered to the laboratory.

It should be emphasised that these two periods are laboratory timeframes for priority testing; they are not medical device registration review timelines and cannot be used directly as the overall Jordanian registration cycle.

Q12 What happens if testing fails? Can a re-test be requested?

Answer: A re-test can be requested, but it must be submitted within the prescribed period.

Under Article 8 of the 2025 Testing Instructions:

  • a re-test application may be filed within 30 days from the date the testing result is issued;
  • the application must state the reasons and be accompanied by the relevant scientific evidence;
  • whether to approve the re-test is decided by the Laboratory Affairs Committee in accordance with the rules.

For non-conforming batches, the JFDA may also take the following measures:

  • refer the non-conforming results to the inspection department;
  • determine the batches and quantities involved based on local production orders or import invoices;
  • place the relevant batches under seal;
  • issue corrective follow-up letters requiring rectification within a prescribed deadline.

For products that fail post-market testing, delisting and recalls may also be required, with the recall deadline determined by the risk profile. Sealed products may ultimately be required to be re-exported or destroyed.

4. Validity, Fees and Post-Market Obligations

Q13 How long is a Jordanian medical device registration certificate valid? What are the registration fees?

Answer: Article 7 of the 2019 Circulation Guidelines addresses renewal: registered medical devices and other products reaching 10 years should be renewed in accordance with JFDA requirements.

It is therefore wrong to assume that Jordan has no registration validity rules, and the widely cited “5-year validity” claim lacks an official basis and should no longer be used.

For fees, the main reference is:

the JFDA Fees and Remuneration Regulation No. 19 of 2015 and its amended text.

The official fee schedule lists fee items for different services, for example:

  • review of medical device circulation licence applications;
  • applications that need to be submitted to the technical committee for review;
  • import invoice processing for medical devices that do not require technical committee review.

These items have different charging bases, and no single fee item can be regarded as a uniform registration fee for all medical devices.

Recommendation: before making a formal quotation, the Jordanian importer should verify the payable fee items with the JFDA based on the product classification, whether registration and testing are required and the specific import business, and keep the official payment notices and financial receipts.

Q14 After registration, what post-market obligations remain?

Answer: After obtaining registration or circulation approval, the companies involved still bear continuing regulatory responsibilities.

The main obligations include:

  • adverse event monitoring: manufacturers, importers and the relevant medical institutions should report medical device adverse events as required;
  • product pricing: the JFDA Directorate of Medical Devices and Supplies has pricing-related functions for medical devices, and registered products should follow the applicable pricing rules;
  • post-market sampling: the JFDA may arrange sampling and testing based on product quality, complaints, non-conformity records, storage and transport conditions and other factors;
  • recalls and corrective actions: for non-conforming products, companies should cooperate in investigations, rectification, recalls and follow-up handling;
  • free sale certificates: eligible locally manufactured Jordanian products may apply for a free sale certificate (FSC) as required.

Companies should therefore clearly define post-market surveillance, complaint handling, recall and documentation maintenance responsibilities in their cooperation agreements.

5. 2026 Regulatory Developments and Practical Issues

Q15 Which new JFDA circulars in 2026 deserve attention?

Answer: As of 13 November 2026, the medical device related items on the latest circular list of the official JFDA website include:

Date issuedCircular subject
29 October 2026Circular on registered sterile medical devices
18 October 2026Circular on the acceptance of electronic certificates in registration dossiers for medical devices and supplies
8 September 2026Circular on deadlines for submitting registration documents

These items signal that companies need to keep monitoring sterile medical devices, electronic certificates and registration dossier submission requirements.

However, the public circular list only allows titles and dates to be verified; the specific scope of application, transition periods and operational requirements cannot be confirmed from it alone. Before formal submission, obtain the full text of the relevant circular and check it with the local importer and the JFDA.

Q16 How can I check whether a medical device is already registered in Jordan?

Answer: Use the official JFDA medical device enquiry system:

https://services.jfda.jo/JFDA/MedicalDevices/MDEnquiry.aspx

The system provides information on medical devices that have been licensed and registered, and can be searched by the following fields:

  • company or store name (Applicant / Store Name);
  • product name (Product Name).

In addition, the JFDA provides a manufacturing site and production line enquiry entry that can be used to verify approval information for manufacturing sites:

https://services.jfda.jo/JFDA/MedicalDevices/ManufSiteEnquiry.aspx

When selecting a Jordanian partner or benchmarking similar products, it is advisable to cross-check using the official systems.

Q17 Does the JFDA accept electronic documents and electronic certificates?

Answer: Yes, but the specific scope of application needs attention.

Article 12 of the 2025 Testing Instructions states clearly that the JFDA may accept electronic documents and may issue testing results, certificates and related attestations electronically for matters covered by the Instructions.

In addition, on 18 October 2026 the JFDA issued a circular on the acceptance of electronic certificates in registration dossiers for medical devices and supplies.

Companies can therefore follow the use of electronic certificates in registration dossiers, but should not assume that electronic documents, electronic signatures and electronic CoAs issued by all countries are automatically accepted. The specific document format should still follow the relevant JFDA requirements.

Q18 What problems do Chinese manufacturers most often encounter when registering in Jordan?

Answer: Mainly the following three:

Pitfall 1: failing to distinguish product classification from registration requirements.

Preparing the dossier for all products on the same registration path, ignoring the differences between Class I and IIa on the one hand and Class IIb and III on the other, as well as the special product requirements of Annex 7.

Pitfall 2: treating the registration certificate as a complete import licence.

Overlooking the initial testing, circulation letter and shipment-by-shipment import approval that the product may require, so that imports still cannot be completed as planned even after the registration approval is obtained.

Pitfall 3: technical documentation not matching laboratory testing requirements.

Inconsistencies between the CoA, the finished product specification, the test methods and the technical file lead the laboratory to request supplementary documents or to reschedule testing.

Q19 How should a local Jordanian importer or authorised partner be selected?

Answer: Focus on verifying three aspects:

  • Entity qualifications: verify the commercial registration, the relevant business licences and the scope of medical device import activities;
  • Regulatory and testing competence: whether the partner is familiar with JFDA registration, laboratory testing, import invoice approvals and post-market regulatory requirements;
  • Cooperation agreement: clearly define dossier management, product registration records, changes, renewals, recalls, document handover after termination and follow-up arrangements.

In particular, clarify who controls the product registration records and technical documentation, so that records remain accessible if the agent or importer is later changed.

Q20 What is Jordanian medical device market access in one sentence?

Answer: The core of Jordanian medical device market access is not simply obtaining a registration certificate, but determining the registration or licensing pathway according to the product classification and completing the applicable testing, circulation and import procedures.

For Chinese manufacturers, the following should be confirmed before the project starts:

  • which class the product belongs to;
  • whether routine registration is required;
  • whether the special requirements of Annex 7 are involved;
  • whether initial laboratory testing is required;
  • whether a circulation letter is required;
  • which approvals are required for each import shipment;
  • who will handle certificate renewal and post-market responsibilities.

Only by clarifying these steps at the project start stage can the registration timeline, fees and subsequent import plans be arranged realistically.

Reference Regulations and Official Enquiry Portals

The following are the main sources verified for this article. Save them and re-confirm the document versions and their current status before starting a project.

Official document or systemMain use
JFDA Law No. 41 of 2008Legal basis of the JFDA as an institution
Drug and Pharmacy Law No. 12 of 2013Legal authority for medical device regulation
2019 Medical Device Circulation GuidelinesClassification, registration, import and circulation requirements
Testing Regulation No. 41 of 2024Basis for testing and circulation oversight
2025 Testing InstructionsTesting, sampling, re-testing and non-conformity handling
Fees and Remuneration Regulation No. 19 of 2015 and amendmentsMedical device related fees
Cosmo e-services systemElectronic submissions and related services
Medical device registration enquiryVerify product registration and licensing
Latest circularsTrack regulatory developments

Disclaimer: this article is based on publicly verifiable JFDA materials as of 13 November 2026 and does not constitute legal advice. For the latest circulars whose full texts are not yet publicly available, this article only lists the officially published information and makes no inference about unverified content. Specific projects are subject to the current JFDA requirements and written replies.

Grzan

Author:Grzan

Get the latest global medical device development and regulatory news, insights and resources.

WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail